The Five Dumbest Things on Wall Street This Week
|Conscience Is His Guidant
Dollens knows when to go
2. HeartthrobsThe heartache is over for Guidant (GDT) and Johnson & Johnson (JNJ).
Only a week ago, the big medical device companies appeared well on their way to an ugly legal standoff. But on Tuesday, they came to terms on a revised merger deal that offers something for everyone. J&J gets a shot at new growth markets at a price it can stomach. Guidant shareholders get $21 billion in cash and stock, locking in gains of recent years. And Guidant chief Ron Dollens finally gets to retire in style.
Last December, when the companies first announced merger plans, J&J projected a third-quarter completion date. Dollens, who by then was looking to head off into the Indianapolis sunset, said he would retire at closing. "The complementary strengths of both firms ... should allow for a very smooth transition," Dollens said during a Dec. 16, 2004, conference call.
But the transition turned rough indeed after safety concerns pushed Guidant to recall a bunch of defibrillators and pacemakers. Those problems, and Guidant's handling of them, led to the last-minute wrangling that had J&J backing away from the table, and Guidant suing its suitor.
Finally, this week the sides worked out a new agreement that's supposed to close in the first quarter of 2006, replete with a $4 billion haircut for Guidant shareholders. And this time around, Dollens is taking no chances. Rather than sticking around to sign all the papers at closing, he said Tuesday he'd step down immediately, to be succeeded on an interim basis by Chairman James Cornelius.
"I am confident that it is the proper time to pursue my previously announced retirement," Dollens said in a press release Tuesday morning. "I've been privileged to lead Guidant over the last 11 years and build a solid foundation of organic growth from innovation, global sales distribution capabilities, access to key markets and a dedicated leadership team."Privilege sounds like the right word. As The Indianapolis Star pointed out last week, Dollens' retirement promises to be a lavish affair. He and Cornelius managed to cash out $33 million worth of Guidant stock in April. They were aided by an unusual provision that vested their stock options upon shareholder approval, not at closing, as is the norm. That little twist allowed Guidant's top two to sell their stock at $74 and change, a sight better than the $62.50 Guidant has been fetching lately. But then, we always knew having a dedicated leadership team would pay off. Dumb-o-Meter score: 88. Only time will tell how many yachts Dollens and Cornelius can water ski behind.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV